Ke. Matthys et al., DUAL EFFECTS OF OXIDIZED LOW-DENSITY-LIPOPROTEIN ON IMMUNE-STIMULATEDNITRIC-OXIDE AND PROSTAGLANDIN RELEASE IN MACROPHAGES, European journal of pharmacology, 298(1), 1996, pp. 97-103
Oxidized low-density lipoprotein (LDL) is currently regarded as a tent
ative key player in atherosclerosis by virtue of its ability to induce
intracellular lipid accumulation and to modulate cell functions in th
e vessel wall. We previously demonstrated that inducible nitric oxide
(NO) synthase activity is attenuated in lipid-laden J774 macrophages o
btained by incubation with oxidized LDL 200 mu g ml(-1) for 24 h. In t
he present study we investigated the effect of oxidized LDL in a lower
concentration (20 mu g ml(-1)) or for a shorter time (6 h) and the po
ssible mediator role of prostaglandin E(2) and prostacyclin. Prostagla
ndins and the NO synthase metabolites citrulline and nitrite were elev
ated in the 24 h supernatant after immune stimulation with interferon-
gamma 100 U ml(-1) with or without lipopolysaccharide 10 mu g ml(-1).
Pretreatment with oxidized LDL 20 mu g ml(-1) for 18 h decreased nitri
te release by 31 +/- 2%, whereas prostaglandin production was not affe
cted. A 6 h pre-exposure to 200 mu g ml(-1) had an opposite effect: it
significantly potentiated interferon-gamma-stimulated prostaglandin E
(2) (10-fold), prostacyclin (7-fold), nitrite (1.5-fold), and citrulli
ne (2.4-fold) release. Indomethacin 10 mu M abolished the prostaglandi
n production and largely prevented the oxidized LDL-dependent increase
in NO synthase activity. Acetylated LDL was without effect. The data
show that the immune-induced release of NO is potentiated or suppresse
d, depending on the conditions of exposure to oxidized LDL. The potent
iation due to short, high-dose exposure is partly mediated by prostagl
andins since indomethacin inhibited both processes.